| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SOX6 SP1 SP3 SP4 USF3 POU2F1 FOXP1 SALL4 ZFHX3 RORC ZNF853 MGA RFXAP CREBBP SOX13 TFAP4 TFCP2 MED12 TBP | 3.55e-09 | 1459 | 54 | 19 | GO:0000977 |
| GeneOntologyMolecularFunction | transcription factor binding | TRERF1 HDAC9 SP1 SP3 PCLO MED12L FOXP1 SALL4 RORC BSN CREBBP TFCP2 MED12 TBP | 8.34e-09 | 753 | 54 | 14 | GO:0008134 |
| GeneOntologyMolecularFunction | transcription coregulator binding | 9.63e-08 | 140 | 54 | 7 | GO:0001221 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SOX6 SP1 SP3 SP4 POU2F1 FOXP1 SALL4 ZFHX3 RORC ZNF853 MGA SOX13 TFAP4 TFCP2 MED12 TBP | 1.04e-07 | 1244 | 54 | 16 | GO:0000978 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.11e-07 | 303 | 54 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SOX6 SP1 SP3 SP4 POU2F1 FOXP1 SALL4 ZFHX3 RORC ZNF853 MGA SOX13 TFAP4 TFCP2 MED12 TBP | 1.39e-07 | 1271 | 54 | 16 | GO:0000987 |
| GeneOntologyMolecularFunction | transcription coregulator activity | TRERF1 MED15 HDAC9 TCF20 BRD4 TOX3 TRIM31 MED12L CREBBP MAML3 MED12 | 2.54e-07 | 562 | 54 | 11 | GO:0003712 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SOX6 SP1 SP3 SP4 USF3 POU2F1 FOXP1 SALL4 ZFHX3 RORC ZNF853 MGA RFXAP SOX13 TFAP4 TFCP2 | 5.78e-07 | 1412 | 54 | 16 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.52e-05 | 417 | 54 | 8 | GO:0061629 | |
| GeneOntologyMolecularFunction | chromatin binding | 2.48e-05 | 739 | 54 | 10 | GO:0003682 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 3.04e-05 | 66 | 54 | 4 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 3.04e-05 | 66 | 54 | 4 | GO:0001098 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | TRERF1 MED15 HDAC9 SP1 TCF20 BRD4 TOX3 TRIM31 MED12L GIGYF2 CREBBP MAML3 MED12 | 4.96e-05 | 1356 | 54 | 13 | GO:0060090 |
| GeneOntologyMolecularFunction | TFIIB-class transcription factor binding | 1.07e-04 | 6 | 54 | 2 | GO:0001093 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.58e-04 | 582 | 54 | 8 | GO:0140297 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 1.99e-04 | 8 | 54 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 2.19e-04 | 320 | 54 | 6 | GO:0001227 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TRERF1 MED15 HDAC9 TCF20 BRD4 TOX3 TRIM31 MED12L CREBBP MAML3 MED12 | 2.31e-04 | 1160 | 54 | 11 | GO:0030674 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 2.42e-04 | 326 | 54 | 6 | GO:0001217 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 3.89e-04 | 11 | 54 | 2 | GO:0099122 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 4.21e-04 | 54 | 54 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 4.44e-04 | 55 | 54 | 3 | GO:0001046 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 7.43e-04 | 560 | 54 | 7 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 7.91e-04 | 566 | 54 | 7 | GO:0001216 | |
| GeneOntologyMolecularFunction | RNA polymerase II core promoter sequence-specific DNA binding | 2.07e-03 | 25 | 54 | 2 | GO:0000979 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 2.41e-03 | 27 | 54 | 2 | GO:0001091 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 4.50e-03 | 37 | 54 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 4.99e-03 | 39 | 54 | 2 | GO:0000993 | |
| GeneOntologyMolecularFunction | histone binding | 5.70e-03 | 265 | 54 | 4 | GO:0042393 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 5.77e-03 | 42 | 54 | 2 | GO:0098918 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 6.60e-03 | 45 | 54 | 2 | GO:0043175 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 7.37e-03 | 147 | 54 | 3 | GO:0042826 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 1.11e-02 | 59 | 54 | 2 | GO:0001222 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.19e-02 | 61 | 54 | 2 | GO:0030374 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TRERF1 SOX6 MED15 PTOV1 SP1 SP3 BMP6 USF3 TCF20 BRD4 TOX3 MED12L POU2F1 FOXP1 MLLT6 SALL4 ZFHX3 MGA RFXAP CREBBP MAML3 TFAP4 TFCP2 MED12 TBP | 1.82e-15 | 1390 | 55 | 25 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TRERF1 SOX6 HDAC9 PHC3 SP3 BMP6 GBP6 SCAF8 POU2F1 FOXP1 SALL4 ZFHX3 RORC CREBBP SOX13 TFAP4 PHC1 | 7.12e-08 | 1399 | 55 | 17 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TRERF1 SOX6 HDAC9 PHC3 SP3 BMP6 GBP6 SCAF8 POU2F1 FOXP1 SALL4 ZFHX3 RORC CREBBP SOX13 TFAP4 PHC1 | 8.22e-08 | 1413 | 55 | 17 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SOX6 HDAC9 SP3 BMP6 GBP6 SCAF8 FOXP1 SALL4 ZFHX3 RORC CREBBP SOX13 | 1.68e-05 | 1053 | 55 | 12 | GO:0000122 |
| GeneOntologyBiologicalProcess | viral transcription | 1.72e-05 | 58 | 55 | 4 | GO:0019083 | |
| GeneOntologyBiologicalProcess | presynapse to nucleus signaling pathway | 2.09e-05 | 3 | 55 | 2 | GO:0099526 | |
| GeneOntologyBiologicalProcess | presynaptic signal transduction | 4.17e-05 | 4 | 55 | 2 | GO:0098928 | |
| GeneOntologyBiologicalProcess | spinal cord oligodendrocyte cell differentiation | 6.95e-05 | 5 | 55 | 2 | GO:0021529 | |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 6.95e-05 | 5 | 55 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | maintenance of presynaptic active zone structure | 1.04e-04 | 6 | 55 | 2 | GO:0048790 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription elongation | 1.77e-04 | 105 | 55 | 4 | GO:0032784 | |
| GeneOntologyBiologicalProcess | viral gene expression | 2.05e-04 | 109 | 55 | 4 | GO:0019080 | |
| GeneOntologyBiologicalProcess | spinal cord development | 2.86e-04 | 119 | 55 | 4 | GO:0021510 | |
| GeneOntologyBiologicalProcess | embryonic process involved in female pregnancy | 3.10e-04 | 10 | 55 | 2 | GO:0060136 | |
| GeneOntologyBiologicalProcess | presynaptic active zone organization | 3.10e-04 | 10 | 55 | 2 | GO:1990709 | |
| GeneOntologyBiologicalProcess | embryo development | SOX6 SP1 SP3 BRD4 NFRKB POU2F1 FOXP1 SALL4 TNRC6C CREBBP MED12 PRRC2B | 3.31e-04 | 1437 | 55 | 12 | GO:0009790 |
| GeneOntologyBiologicalProcess | mRNA transcription by RNA polymerase II | 3.61e-04 | 52 | 55 | 3 | GO:0042789 | |
| GeneOntologyBiologicalProcess | mRNA transcription | 4.74e-04 | 57 | 55 | 3 | GO:0009299 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 5.23e-04 | 382 | 55 | 6 | GO:0030217 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 5.36e-04 | 537 | 55 | 7 | GO:0030098 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription elongation | 5.89e-04 | 144 | 55 | 4 | GO:0006354 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription, elongation | 6.07e-04 | 62 | 55 | 3 | GO:0032786 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 6.22e-04 | 14 | 55 | 2 | GO:0060213 | |
| GeneOntologyBiologicalProcess | myeloid progenitor cell differentiation | 6.22e-04 | 14 | 55 | 2 | GO:0002318 | |
| GeneOntologyBiologicalProcess | cell differentiation in spinal cord | 6.36e-04 | 63 | 55 | 3 | GO:0021515 | |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell differentiation | 7.17e-04 | 15 | 55 | 2 | GO:0045586 | |
| GeneOntologyBiologicalProcess | negative regulation by host of viral transcription | 7.17e-04 | 15 | 55 | 2 | GO:0043922 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 8.18e-04 | 16 | 55 | 2 | GO:0060211 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 8.18e-04 | 16 | 55 | 2 | GO:1900153 | |
| GeneOntologyBiologicalProcess | enucleate erythrocyte differentiation | 8.18e-04 | 16 | 55 | 2 | GO:0043353 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription initiation by RNA polymerase II | 8.65e-04 | 70 | 55 | 3 | GO:0060261 | |
| GeneOntologyBiologicalProcess | synaptic vesicle localization | 9.02e-04 | 71 | 55 | 3 | GO:0097479 | |
| GeneOntologyBiologicalProcess | DNA damage response | 9.05e-04 | 959 | 55 | 9 | GO:0006974 | |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell activation | 9.25e-04 | 17 | 55 | 2 | GO:0046643 | |
| GeneOntologyBiologicalProcess | inner cell mass cell proliferation | 9.25e-04 | 17 | 55 | 2 | GO:0001833 | |
| GeneOntologyBiologicalProcess | positive regulation by host of viral transcription | 9.25e-04 | 17 | 55 | 2 | GO:0043923 | |
| GeneOntologyCellularComponent | transcription regulator complex | TRERF1 SOX6 MED15 PTOV1 HDAC9 SP1 SP3 POU2F1 SALL4 ZFHX3 MGA RFXAP CREBBP TFAP4 TFCP2 TBP | 1.21e-12 | 596 | 54 | 16 | GO:0005667 |
| GeneOntologyCellularComponent | chromatin | SOX6 SP1 SP3 SP4 BRD4 NFRKB POU2F1 FOXP1 SALL4 ZFHX3 RORC MGA CREBBP SOX13 TFAP4 TFCP2 PHC1 TBP | 1.50e-08 | 1480 | 54 | 18 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TRERF1 MED15 HDAC9 PHC3 INTS7 SCAF8 BRD4 NFRKB MED12L POU2F1 MGA RFXAP CREBBP MED12 PHC1 TBP | 2.23e-07 | 1377 | 54 | 16 | GO:0140513 |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 1.82e-04 | 8 | 54 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | nuclear body | 4.65e-04 | 903 | 54 | 9 | GO:0016604 | |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 5.84e-04 | 14 | 54 | 2 | GO:0099569 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 6.76e-04 | 272 | 54 | 5 | GO:0090575 | |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 9.76e-04 | 18 | 54 | 2 | GO:0019908 | |
| GeneOntologyCellularComponent | PRC1 complex | 1.09e-03 | 19 | 54 | 2 | GO:0035102 | |
| GeneOntologyCellularComponent | transcription repressor complex | 1.48e-03 | 87 | 54 | 3 | GO:0017053 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 1.60e-03 | 23 | 54 | 2 | GO:0098831 | |
| GeneOntologyCellularComponent | inhibitory synapse | 2.90e-03 | 31 | 54 | 2 | GO:0060077 | |
| GeneOntologyCellularComponent | ribbon synapse | 3.09e-03 | 32 | 54 | 2 | GO:0097470 | |
| GeneOntologyCellularComponent | transferase complex | 3.12e-03 | 963 | 54 | 8 | GO:1990234 | |
| HumanPheno | Frontal upsweep of hair | 9.84e-06 | 33 | 22 | 4 | HP:0002236 | |
| HumanPheno | Abnormal hair whorl | 2.62e-05 | 42 | 22 | 4 | HP:0010721 | |
| HumanPheno | Prominent fingertip pads | 3.78e-05 | 46 | 22 | 4 | HP:0001212 | |
| HumanPheno | Prominent digit pad | 4.48e-05 | 48 | 22 | 4 | HP:0011298 | |
| HumanPheno | Diagnostic behavioral phenotype | SOX6 USF3 TCF20 BRD4 MED12L TNRC6B GIGYF2 FOXP1 QRICH1 CREBBP MED12 | 9.40e-05 | 747 | 22 | 11 | HP:0025783 |
| Domain | Sp1_fam | 2.55e-06 | 10 | 53 | 3 | IPR030450 | |
| Domain | Mediator_Med12_catenin-bd | 7.90e-06 | 2 | 53 | 2 | IPR021989 | |
| Domain | Znf_piccolo | 7.90e-06 | 2 | 53 | 2 | IPR008899 | |
| Domain | zf-piccolo | 7.90e-06 | 2 | 53 | 2 | PF05715 | |
| Domain | Med12-PQL | 7.90e-06 | 2 | 53 | 2 | PF12144 | |
| Domain | Med12-LCEWAV | 7.90e-06 | 2 | 53 | 2 | PF12145 | |
| Domain | Mediator_Med12 | 7.90e-06 | 2 | 53 | 2 | IPR019035 | |
| Domain | Med12 | 7.90e-06 | 2 | 53 | 2 | SM01281 | |
| Domain | Med12 | 7.90e-06 | 2 | 53 | 2 | PF09497 | |
| Domain | Mediator_Med12_LCEWAV | 7.90e-06 | 2 | 53 | 2 | IPR021990 | |
| Domain | Ago_hook | 2.37e-05 | 3 | 53 | 2 | PF10427 | |
| Domain | BAT2_N | 2.37e-05 | 3 | 53 | 2 | IPR009738 | |
| Domain | BAT2_N | 2.37e-05 | 3 | 53 | 2 | PF07001 | |
| Domain | TNRC6-PABC_bdg | 2.37e-05 | 3 | 53 | 2 | PF16608 | |
| Domain | TNRC6_PABC-bd | 2.37e-05 | 3 | 53 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 2.37e-05 | 3 | 53 | 2 | IPR019486 | |
| Domain | PRRC2 | 2.37e-05 | 3 | 53 | 2 | IPR033184 | |
| Domain | Znf_FCS | 7.86e-05 | 5 | 53 | 2 | IPR012313 | |
| Domain | ZF_FCS | 1.18e-04 | 6 | 53 | 2 | PS51024 | |
| Domain | HMG_box | 4.57e-04 | 53 | 53 | 3 | PF00505 | |
| Domain | HMG_BOX_2 | 4.83e-04 | 54 | 53 | 3 | PS50118 | |
| Domain | HMG | 4.83e-04 | 54 | 53 | 3 | SM00398 | |
| Domain | - | 5.10e-04 | 55 | 53 | 3 | 1.10.30.10 | |
| Domain | Znf_FYVE_PHD | 8.00e-04 | 147 | 53 | 4 | IPR011011 | |
| Domain | HMG_box_dom | 8.32e-04 | 65 | 53 | 3 | IPR009071 | |
| Domain | ZINC_FINGER_C2H2_2 | 1.44e-03 | 775 | 53 | 8 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 1.46e-03 | 777 | 53 | 8 | PS00028 | |
| Domain | Znf_C2H2-like | 1.70e-03 | 796 | 53 | 8 | IPR015880 | |
| Domain | EPHD | 1.76e-03 | 22 | 53 | 2 | PS51805 | |
| Domain | Znf_C2H2 | 1.83e-03 | 805 | 53 | 8 | IPR007087 | |
| Domain | ZnF_C2H2 | 1.87e-03 | 808 | 53 | 8 | SM00355 | |
| Domain | Bromodomain_CS | 2.46e-03 | 26 | 53 | 2 | IPR018359 | |
| Domain | - | 2.93e-03 | 679 | 53 | 7 | 3.30.160.60 | |
| Domain | zf-C2H2 | 3.28e-03 | 693 | 53 | 7 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 3.31e-03 | 694 | 53 | 7 | IPR013087 | |
| Domain | HLH | 3.86e-03 | 111 | 53 | 3 | PF00010 | |
| Domain | HLH | 4.36e-03 | 116 | 53 | 3 | SM00353 | |
| Domain | SAM/pointed | 4.47e-03 | 117 | 53 | 3 | IPR013761 | |
| Domain | BHLH | 4.47e-03 | 117 | 53 | 3 | PS50888 | |
| Domain | bHLH_dom | 4.58e-03 | 118 | 53 | 3 | IPR011598 | |
| Domain | BROMODOMAIN_1 | 4.94e-03 | 37 | 53 | 2 | PS00633 | |
| Domain | Bromodomain | 5.20e-03 | 38 | 53 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 6.04e-03 | 41 | 53 | 2 | PS50014 | |
| Domain | BROMO | 6.33e-03 | 42 | 53 | 2 | SM00297 | |
| Domain | Bromodomain | 6.33e-03 | 42 | 53 | 2 | IPR001487 | |
| Domain | - | 6.33e-03 | 42 | 53 | 2 | 1.20.920.10 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | MED15 HDAC9 SP1 PHC3 INTS7 TNRC6B POU2F1 ZFHX3 RORC TNRC6C MGA CREBBP MAML3 MED12 PHC1 TBP | 4.01e-06 | 1387 | 46 | 16 | M734 |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 8.33e-06 | 149 | 46 | 6 | M27888 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 4.06e-05 | 197 | 46 | 6 | M27188 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 4.94e-05 | 301 | 46 | 7 | MM15983 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 5.18e-05 | 125 | 46 | 5 | M27186 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 5.81e-05 | 65 | 46 | 4 | M39682 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 7.11e-05 | 25 | 46 | 3 | MM15546 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 7.50e-05 | 220 | 46 | 6 | M27794 | |
| Pathway | REACTOME_PTEN_REGULATION | 8.59e-05 | 139 | 46 | 5 | M27646 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES | 9.16e-05 | 73 | 46 | 4 | MM15349 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 1.01e-04 | 28 | 46 | 3 | M48253 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.01e-04 | 28 | 46 | 3 | M6177 | |
| Pathway | WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE | 1.04e-04 | 5 | 46 | 2 | M45554 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES | 1.37e-04 | 81 | 46 | 4 | M27647 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 1.44e-04 | 82 | 46 | 4 | M2 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 1.51e-04 | 32 | 46 | 3 | M48012 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 1.51e-04 | 32 | 46 | 3 | M39521 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 1.55e-04 | 6 | 46 | 2 | MM1564 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 1.55e-04 | 6 | 46 | 2 | M22047 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 1.81e-04 | 34 | 46 | 3 | M46422 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 1.81e-04 | 34 | 46 | 3 | M27826 | |
| Pathway | REACTOME_ONCOGENE_INDUCED_SENESCENCE | 1.98e-04 | 35 | 46 | 3 | M27190 | |
| Pathway | BIOCARTA_TERT_PATHWAY | 2.16e-04 | 7 | 46 | 2 | MM1541 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 2.16e-04 | 7 | 46 | 2 | M46421 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 2.65e-04 | 96 | 46 | 4 | M27784 | |
| Pathway | BIOCARTA_TERT_PATHWAY | 2.88e-04 | 8 | 46 | 2 | M22015 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 3.48e-04 | 1022 | 46 | 11 | MM15436 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 3.70e-04 | 9 | 46 | 2 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 3.70e-04 | 9 | 46 | 2 | M46436 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 3.76e-04 | 296 | 46 | 6 | M27869 | |
| Pathway | PID_HNF3A_PATHWAY | 3.92e-04 | 44 | 46 | 3 | M285 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 3.92e-04 | 44 | 46 | 3 | M27295 | |
| Pathway | WP_SELENIUM_METABOLISM_SELENOPROTEINS | 4.19e-04 | 45 | 46 | 3 | MM15877 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 4.61e-04 | 10 | 46 | 2 | M48013 | |
| Pathway | WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS | 4.77e-04 | 47 | 46 | 3 | M48301 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 5.07e-04 | 48 | 46 | 3 | M611 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 5.39e-04 | 49 | 46 | 3 | M48250 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 5.62e-04 | 11 | 46 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 5.80e-04 | 118 | 46 | 4 | M27316 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 5.99e-04 | 119 | 46 | 4 | M607 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 7.94e-04 | 13 | 46 | 2 | M46434 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 8.85e-04 | 58 | 46 | 3 | M29616 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 8.85e-04 | 58 | 46 | 3 | M11980 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 9.25e-04 | 14 | 46 | 2 | M27808 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.01e-03 | 237 | 46 | 5 | M27786 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 1.03e-03 | 61 | 46 | 3 | M27811 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.19e-03 | 246 | 46 | 5 | M10189 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 1.19e-03 | 143 | 46 | 4 | M39591 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS | 1.21e-03 | 16 | 46 | 2 | M27403 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.21e-03 | 16 | 46 | 2 | M27121 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 1.29e-03 | 66 | 46 | 3 | M101 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 1.37e-03 | 17 | 46 | 2 | M27788 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 1.54e-03 | 18 | 46 | 2 | M3430 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 1.54e-03 | 18 | 46 | 2 | MM1385 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 1.72e-03 | 19 | 46 | 2 | M48238 | |
| Pathway | WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS | 1.76e-03 | 159 | 46 | 4 | M39373 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.79e-03 | 74 | 46 | 3 | M616 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.91e-03 | 20 | 46 | 2 | M27881 | |
| Pathway | WP_ESTROGEN_SIGNALING | 2.01e-03 | 77 | 46 | 3 | MM15934 | |
| Pathway | PID_REG_GR_PATHWAY | 2.40e-03 | 82 | 46 | 3 | M115 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 2.58e-03 | 84 | 46 | 3 | M1008 | |
| Pathway | PID_CMYB_PATHWAY | 2.58e-03 | 84 | 46 | 3 | M195 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 2.75e-03 | 86 | 46 | 3 | M2642 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.98e-03 | 25 | 46 | 2 | M27880 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 3.09e-03 | 768 | 46 | 8 | MM14851 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 3.13e-03 | 90 | 46 | 3 | M820 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 3.22e-03 | 26 | 46 | 2 | M2499 | |
| Pathway | REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER | 3.22e-03 | 26 | 46 | 2 | MM15458 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 3.22e-03 | 26 | 46 | 2 | M47923 | |
| Pathway | REACTOME_SUMOYLATION | 3.29e-03 | 189 | 46 | 4 | M27214 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 3.40e-03 | 313 | 46 | 5 | M27867 | |
| Pathway | REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER | 3.73e-03 | 28 | 46 | 2 | M1022 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 3.98e-03 | 98 | 46 | 3 | M48247 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 4.26e-03 | 330 | 46 | 5 | M7847 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS | 4.56e-03 | 31 | 46 | 2 | M27393 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 4.85e-03 | 32 | 46 | 2 | M27900 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 4.85e-03 | 32 | 46 | 2 | MM14975 | |
| Pathway | PID_HIF2PATHWAY | 5.47e-03 | 34 | 46 | 2 | M44 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 5.47e-03 | 34 | 46 | 2 | MM15531 | |
| Pathway | REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION | 5.47e-03 | 34 | 46 | 2 | MM15435 | |
| Pathway | REACTOME_ADIPOGENESIS | 5.50e-03 | 110 | 46 | 3 | M48259 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 6.45e-03 | 37 | 46 | 2 | M27797 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 6.45e-03 | 37 | 46 | 2 | M29790 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 6.52e-03 | 117 | 46 | 3 | M19248 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 7.00e-03 | 120 | 46 | 3 | M48233 | |
| Pathway | PID_FOXM1_PATHWAY | 7.51e-03 | 40 | 46 | 2 | M176 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 7.51e-03 | 40 | 46 | 2 | MM15000 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GENE_SILENCING_BY_METHYLATION_OF_H3K27_AND_UBIQUITINATION_OF_H2AK119 | 7.51e-03 | 40 | 46 | 2 | M47917 | |
| Pubmed | TRERF1 SOX6 MED15 SP1 PHC3 TCF20 SCAF8 NFRKB TNRC6B GIGYF2 POU2F1 FOXP1 MLLT6 ZFHX3 RAI14 TNRC6C MGA RFXAP CREBBP SOX13 PRRC2A TFAP4 TFCP2 PRRC2B TBP | 2.94e-20 | 1429 | 56 | 25 | 35140242 | |
| Pubmed | TRERF1 SOX6 SP1 SP3 SP4 TCF20 BRD4 TOX3 POU2F1 FOXP1 MLLT6 SALL4 ZFHX3 MGA SOX13 TFAP4 TFCP2 PHC1 TBP | 1.39e-17 | 808 | 56 | 19 | 20412781 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TRERF1 MED15 TCF20 NFRKB POU2F1 FOXP1 ZFHX3 MGA CREBBP SOX13 TFAP4 MED12 PRRC2B | 1.15e-14 | 351 | 56 | 13 | 38297188 |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | SOX6 HDAC9 SP1 TCF20 TOX3 TRIM31 POU2F1 FOXP1 SALL4 RAI14 RORC RFXAP CREBBP MAML3 TFCP2 TBP | 3.79e-13 | 877 | 56 | 16 | 20211142 |
| Pubmed | 1.31e-12 | 23 | 56 | 6 | 9225980 | ||
| Pubmed | TRERF1 PHC3 TCF20 BRD4 TNRC6B GIGYF2 FOXP1 ZFHX3 RAI14 MGA MED12 PHC1 | 2.69e-12 | 418 | 56 | 12 | 34709266 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TRERF1 SOX6 SP1 SP3 SP4 USF3 TOX3 POU2F1 FOXP1 ZFHX3 RORC MGA SOX13 TFAP4 TFCP2 | 9.55e-12 | 908 | 56 | 15 | 19274049 |
| Pubmed | 1.63e-11 | 268 | 56 | 10 | 33640491 | ||
| Pubmed | MED15 TCF20 BRD4 NFRKB TNRC6B GIGYF2 RAI14 MGA CREBBP PRRC2A MED12 PRRC2B | 6.31e-11 | 549 | 56 | 12 | 38280479 | |
| Pubmed | SP1 SP3 TCF20 BRD4 POU2F1 ZFHX3 RORC QRICH1 CREBBP SOX13 MAML3 TFAP4 PHC1 | 7.96e-11 | 709 | 56 | 13 | 22988430 | |
| Pubmed | TRERF1 MED15 SP4 TCF20 BRD4 NFRKB POU2F1 FOXP1 MLLT6 QRICH1 CREBBP PRRC2A TFAP4 MED12 PRRC2B | 1.45e-10 | 1103 | 56 | 15 | 34189442 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TRERF1 SP1 PHC3 TCF20 SCAF8 BRD4 MINK1 NFRKB PPP1R18 GIGYF2 POU2F1 PRRC2A TFAP4 | 2.33e-10 | 774 | 56 | 13 | 15302935 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 7.67e-10 | 398 | 56 | 10 | 35016035 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 23540600 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 26967243 | ||
| Pubmed | Curcumin decreases specificity protein expression in bladder cancer cells. | 3.95e-09 | 3 | 56 | 3 | 18593936 | |
| Pubmed | Complex phenotype of mice homozygous for a null mutation in the Sp4 transcription factor gene. | 3.95e-09 | 3 | 56 | 3 | 11532028 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 21919647 | ||
| Pubmed | Functional analyses of the transcription factor Sp4 reveal properties distinct from Sp1 and Sp3. | 3.95e-09 | 3 | 56 | 3 | 7559627 | |
| Pubmed | MED15 PHC3 SP3 TOMM22 INTS7 SCAF8 MINK1 NFRKB PPP1R18 TNRC6B ZFHX3 RAI14 PRRC2A MED12 TBP | 9.25e-09 | 1497 | 56 | 15 | 31527615 | |
| Pubmed | 9.65e-09 | 94 | 56 | 6 | 16325481 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 9.87e-09 | 167 | 56 | 7 | 20362541 | |
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 15781457 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 10215616 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 27889927 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 23133566 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.81e-08 | 430 | 56 | 9 | 35044719 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 3.79e-08 | 203 | 56 | 7 | 22083510 | |
| Pubmed | 3.94e-08 | 5 | 56 | 3 | 10362258 | ||
| Pubmed | 3.94e-08 | 5 | 56 | 3 | 20538607 | ||
| Pubmed | 3.94e-08 | 5 | 56 | 3 | 10547281 | ||
| Pubmed | 3.94e-08 | 5 | 56 | 3 | 12560508 | ||
| Pubmed | 3.94e-08 | 5 | 56 | 3 | 16061936 | ||
| Pubmed | Composite co-activator ARC mediates chromatin-directed transcriptional activation. | 5.22e-08 | 23 | 56 | 4 | 10235267 | |
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 16201967 | ||
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 16734381 | ||
| Pubmed | 1.26e-07 | 242 | 56 | 7 | 34011540 | ||
| Pubmed | 1.38e-07 | 7 | 56 | 3 | 12004059 | ||
| Pubmed | 2.21e-07 | 263 | 56 | 7 | 20932939 | ||
| Pubmed | Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. | 4.71e-07 | 10 | 56 | 3 | 15619633 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAGI1 USF3 SCAF8 MINK1 TOX3 TNRC6B FOXP1 ZFHX3 RAI14 TNRC6C CREBBP MAML3 TFAP4 | 5.21e-07 | 1489 | 56 | 13 | 28611215 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 5.24e-07 | 608 | 56 | 9 | 36089195 | |
| Pubmed | PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. | 5.84e-07 | 41 | 56 | 4 | 22325352 | |
| Pubmed | 6.40e-07 | 453 | 56 | 8 | 29656893 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 6.84e-07 | 457 | 56 | 8 | 32344865 | |
| Pubmed | 1.08e-06 | 486 | 56 | 8 | 20936779 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 8668525 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 10825178 | ||
| Pubmed | HPV8 activates cellular gene expression mainly through Sp1/3 binding sites. | 2.55e-06 | 2 | 56 | 2 | 31299490 | |
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 2.55e-06 | 2 | 56 | 2 | 23403927 | |
| Pubmed | O-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1. | 2.55e-06 | 2 | 56 | 2 | 19070619 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 25175639 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 14766015 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 25538045 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 8230415 | ||
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 2.55e-06 | 2 | 56 | 2 | 26793095 | |
| Pubmed | Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors. | 2.55e-06 | 2 | 56 | 2 | 31164147 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 20332206 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 17681019 | ||
| Pubmed | Endothelial Sp1/Sp3 are essential to the effect of captopril on blood pressure in male mice. | 2.55e-06 | 2 | 56 | 2 | 37735515 | |
| Pubmed | MED12 and BRD4 cooperate to sustain cancer growth upon loss of mediator kinase. | 2.55e-06 | 2 | 56 | 2 | 34910943 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 26807725 | ||
| Pubmed | An Sp1/Sp3 binding polymorphism confers methylation protection. | 2.55e-06 | 2 | 56 | 2 | 18725933 | |
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 2.55e-06 | 2 | 56 | 2 | 21935939 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 15951564 | ||
| Pubmed | Transcription factors Sp1 and Sp3 regulate basal transcription of the human IRF-3 gene. | 2.55e-06 | 2 | 56 | 2 | 22464952 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 19437621 | ||
| Pubmed | Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. | 2.55e-06 | 2 | 56 | 2 | 8845379 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 9041129 | ||
| Pubmed | Transcriptional control of human CD2AP expression: the role of Sp1 and Sp3. | 2.55e-06 | 2 | 56 | 2 | 21604172 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 1454515 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 21248046 | ||
| Pubmed | Promoter activity of Tat at steps subsequent to TATA-binding protein recruitment. | 2.55e-06 | 2 | 56 | 2 | 9372921 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 27321892 | ||
| Pubmed | Sp1 and Sp3 activate transcription of the human dopamine transporter gene. | 2.55e-06 | 2 | 56 | 2 | 15816870 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 32493491 | ||
| Pubmed | Sp family transcription factors regulate expression of rat D2 dopamine receptor gene. | 2.55e-06 | 2 | 56 | 2 | 9628590 | |
| Pubmed | The nuclear abundance of transcription factors Sp1 and Sp3 depends on biotin in Jurkat cells. | 2.55e-06 | 2 | 56 | 2 | 14608051 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 23941741 | ||
| Pubmed | Differentiation-dependent and cell-specific regulation of the hIGFBP-1 gene in human endometrium. | 2.55e-06 | 2 | 56 | 2 | 9329821 | |
| Pubmed | Synaptic activity controls localization and function of CtBP1 via binding to Bassoon and Piccolo. | 2.55e-06 | 2 | 56 | 2 | 25652077 | |
| Pubmed | TRERF1 MAGI1 TCF20 MINK1 TNRC6B GIGYF2 BSN MGA PRRC2A PRRC2B | 2.84e-06 | 963 | 56 | 10 | 28671696 | |
| Pubmed | An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. | 3.76e-06 | 19 | 56 | 3 | 16799563 | |
| Pubmed | 3.79e-06 | 65 | 56 | 4 | 22496869 | ||
| Pubmed | 4.76e-06 | 152 | 56 | 5 | 38360978 | ||
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 4.82e-06 | 69 | 56 | 4 | 28481362 | |
| Pubmed | 5.66e-06 | 608 | 56 | 8 | 16713569 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 7.13e-06 | 444 | 56 | 7 | 34795231 | |
| Pubmed | 7.47e-06 | 77 | 56 | 4 | 19505873 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 15821099 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 17652716 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 9525610 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 12730302 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 18417714 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 12694199 | ||
| Pubmed | Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. | 7.63e-06 | 3 | 56 | 2 | 14701757 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 15118068 | ||
| Pubmed | The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication. | 7.63e-06 | 3 | 56 | 2 | 8207805 | |
| Pubmed | Modulation of Bone Morphogenetic Protein (BMP) 2 gene expression by Sp1 transcription factors. | 7.63e-06 | 3 | 56 | 2 | 17317039 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 11850421 | ||
| Interaction | CRX interactions | TRERF1 MED15 SP1 SP3 SP4 TCF20 NFRKB POU2F1 FOXP1 MLLT6 ZFHX3 QRICH1 MGA CREBBP TFAP4 MED12 PRRC2B | 9.28e-20 | 254 | 54 | 17 | int:CRX |
| Interaction | HDAC1 interactions | TRERF1 SOX6 PTOV1 HDAC9 SP1 SP3 TCF20 BRD4 TNRC6B GIGYF2 POU2F1 SALL4 ZFHX3 RAI14 RORC MGA CREBBP TFAP4 TFCP2 MED12 TBP | 2.66e-13 | 1108 | 54 | 21 | int:HDAC1 |
| Interaction | FEV interactions | 1.40e-10 | 203 | 54 | 10 | int:FEV | |
| Interaction | PAX6 interactions | NFRKB POU2F1 FOXP1 MLLT6 ZFHX3 QRICH1 MGA RFXAP CREBBP TFAP4 PRRC2B TBP | 1.86e-10 | 366 | 54 | 12 | int:PAX6 |
| Interaction | TLE3 interactions | TRERF1 SOX6 MED15 PHC3 TCF20 SCAF8 BRD4 NFRKB MLLT6 ZFHX3 QRICH1 CREBBP | 2.53e-10 | 376 | 54 | 12 | int:TLE3 |
| Interaction | CTBP1 interactions | SOX6 MED15 HDAC9 SP1 PHC3 BRD4 PCLO FOXP1 CREBBP TFAP4 PRRC2B TBP | 6.08e-10 | 406 | 54 | 12 | int:CTBP1 |
| Interaction | HNF1B interactions | 1.80e-09 | 190 | 54 | 9 | int:HNF1B | |
| Interaction | POU5F1 interactions | SP1 TCF20 SCAF8 BRD4 NFRKB GIGYF2 SALL4 ZFHX3 RAI14 MGA PRRC2B PHC1 TBP | 3.32e-09 | 584 | 54 | 13 | int:POU5F1 |
| Interaction | NFIX interactions | 8.53e-09 | 227 | 54 | 9 | int:NFIX | |
| Interaction | SOX6 interactions | 8.71e-09 | 157 | 54 | 8 | int:SOX6 | |
| Interaction | NFYC interactions | 2.23e-08 | 177 | 54 | 8 | int:NFYC | |
| Interaction | ESRRB interactions | 2.95e-08 | 262 | 54 | 9 | int:ESRRB | |
| Interaction | AR interactions | TRERF1 MED15 SP1 TCF20 BRD4 NFRKB MED12L POU2F1 FOXP1 ZFHX3 MGA CREBBP MED12 PRRC2B TBP | 3.09e-08 | 992 | 54 | 15 | int:AR |
| Interaction | HDAC4 interactions | PTOV1 HDAC9 MAGI1 SP1 INTS7 SCAF8 NFRKB FMN2 TNRC6B GIGYF2 RFXAP PRRC2A PRRC2B | 5.83e-08 | 744 | 54 | 13 | int:HDAC4 |
| Interaction | CEBPA interactions | TRERF1 MED15 SP4 TCF20 INTS7 BRD4 NFRKB POU2F1 FOXP1 MLLT6 QRICH1 CREBBP PRRC2A TFAP4 MED12 PRRC2B | 9.23e-08 | 1245 | 54 | 16 | int:CEBPA |
| Interaction | SP3 interactions | 9.63e-08 | 84 | 54 | 6 | int:SP3 | |
| Interaction | CNOT9 interactions | 1.74e-07 | 231 | 54 | 8 | int:CNOT9 | |
| Interaction | SOX5 interactions | 2.46e-07 | 162 | 54 | 7 | int:SOX5 | |
| Interaction | TFCP2L1 interactions | 2.57e-07 | 99 | 54 | 6 | int:TFCP2L1 | |
| Interaction | MED10 interactions | 3.07e-07 | 102 | 54 | 6 | int:MED10 | |
| Interaction | EGR2 interactions | 3.54e-07 | 171 | 54 | 7 | int:EGR2 | |
| Interaction | NFYA interactions | 3.65e-07 | 105 | 54 | 6 | int:NFYA | |
| Interaction | EWSR1 interactions | MED15 TCF20 TOMM22 BRD4 PCLO NFRKB TRIM31 SALL4 RAI14 RORC RFXAP CREBBP PRRC2A | 5.61e-07 | 906 | 54 | 13 | int:EWSR1 |
| Interaction | SIN3A interactions | 6.89e-07 | 380 | 54 | 9 | int:SIN3A | |
| Interaction | MNAT1 interactions | 7.65e-07 | 119 | 54 | 6 | int:MNAT1 | |
| Interaction | KLF5 interactions | 8.59e-07 | 195 | 54 | 7 | int:KLF5 | |
| Interaction | KDM1A interactions | TRERF1 SOX6 PHC3 TCF20 BRD4 TNRC6B GIGYF2 FOXP1 ZFHX3 RAI14 MGA MED12 PHC1 | 8.61e-07 | 941 | 54 | 13 | int:KDM1A |
| Interaction | SUMO1 interactions | 9.05e-07 | 287 | 54 | 8 | int:SUMO1 | |
| Interaction | E2F1 interactions | 1.02e-06 | 200 | 54 | 7 | int:E2F1 | |
| Interaction | BMI1 interactions | PHC3 SCAF8 BRD4 TNRC6B GIGYF2 MGA CREBBP PRRC2A MED12 PRRC2B PHC1 | 1.12e-06 | 659 | 54 | 11 | int:BMI1 |
| Interaction | SP7 interactions | 1.39e-06 | 304 | 54 | 8 | int:SP7 | |
| Interaction | MDC1 interactions | 1.40e-06 | 414 | 54 | 9 | int:MDC1 | |
| Interaction | NFIC interactions | 1.41e-06 | 210 | 54 | 7 | int:NFIC | |
| Interaction | SMG7 interactions | 1.99e-06 | 319 | 54 | 8 | int:SMG7 | |
| Interaction | KLF8 interactions | 2.51e-06 | 329 | 54 | 8 | int:KLF8 | |
| Interaction | MSX1 interactions | 2.54e-06 | 36 | 54 | 4 | int:MSX1 | |
| Interaction | YY1 interactions | 2.99e-06 | 454 | 54 | 9 | int:YY1 | |
| Interaction | GSC interactions | 3.57e-06 | 87 | 54 | 5 | int:GSC | |
| Interaction | FLOT1 interactions | 4.32e-06 | 475 | 54 | 9 | int:FLOT1 | |
| Interaction | MBD2 interactions | 4.45e-06 | 161 | 54 | 6 | int:MBD2 | |
| Interaction | YAP1 interactions | TRERF1 MED15 TCF20 BRD4 NFRKB TNRC6B GIGYF2 RAI14 MGA CREBBP PRRC2A TFCP2 MED12 | 4.62e-06 | 1095 | 54 | 13 | int:YAP1 |
| Interaction | CNOT6L interactions | 4.97e-06 | 93 | 54 | 5 | int:CNOT6L | |
| Interaction | RBPJ interactions | 4.97e-06 | 254 | 54 | 7 | int:RBPJ | |
| Interaction | RELA interactions | 5.11e-06 | 485 | 54 | 9 | int:RELA | |
| Interaction | BAG2 interactions | 5.13e-06 | 622 | 54 | 10 | int:BAG2 | |
| Interaction | RCOR1 interactions | 5.93e-06 | 494 | 54 | 9 | int:RCOR1 | |
| Interaction | SNRNP40 interactions | 6.33e-06 | 637 | 54 | 10 | int:SNRNP40 | |
| Interaction | MED23 interactions | 6.73e-06 | 266 | 54 | 7 | int:MED23 | |
| Interaction | SP4 interactions | 6.91e-06 | 46 | 54 | 4 | int:SP4 | |
| Interaction | POU2F1 interactions | 7.19e-06 | 175 | 54 | 6 | int:POU2F1 | |
| Interaction | TEAD1 interactions | 7.43e-06 | 176 | 54 | 6 | int:TEAD1 | |
| Interaction | FBRS interactions | 7.82e-06 | 102 | 54 | 5 | int:FBRS | |
| Interaction | CNOT2 interactions | 7.93e-06 | 178 | 54 | 6 | int:CNOT2 | |
| Interaction | RPS20 interactions | 8.03e-06 | 513 | 54 | 9 | int:RPS20 | |
| Interaction | HNF4A interactions | 8.36e-06 | 275 | 54 | 7 | int:HNF4A | |
| Interaction | FBXL19 interactions | 9.43e-06 | 106 | 54 | 5 | int:FBXL19 | |
| Interaction | FHL2 interactions | 9.78e-06 | 396 | 54 | 8 | int:FHL2 | |
| Interaction | MED26 interactions | 9.87e-06 | 107 | 54 | 5 | int:MED26 | |
| Interaction | LHX3 interactions | 9.88e-06 | 185 | 54 | 6 | int:LHX3 | |
| Interaction | FMR1 interactions | 1.14e-05 | 536 | 54 | 9 | int:FMR1 | |
| Interaction | SCMH1 interactions | 1.32e-05 | 54 | 54 | 4 | int:SCMH1 | |
| Interaction | HMGA1 interactions | 1.47e-05 | 419 | 54 | 8 | int:HMGA1 | |
| Interaction | HDAC2 interactions | 1.51e-05 | 865 | 54 | 11 | int:HDAC2 | |
| Interaction | BCOR interactions | 1.53e-05 | 302 | 54 | 7 | int:BCOR | |
| Interaction | WWTR1 interactions | 1.55e-05 | 422 | 54 | 8 | int:WWTR1 | |
| Interaction | NUP35 interactions | 1.60e-05 | 424 | 54 | 8 | int:NUP35 | |
| Interaction | NR2F1 interactions | 1.75e-05 | 58 | 54 | 4 | int:NR2F1 | |
| Interaction | CBX4 interactions | 1.77e-05 | 205 | 54 | 6 | int:CBX4 | |
| Interaction | ETS1 interactions | 1.79e-05 | 121 | 54 | 5 | int:ETS1 | |
| Interaction | CEBPB interactions | HDAC9 SP1 PHC3 SP3 TCF20 TOMM22 BRD4 POU2F1 FOXP1 QRICH1 CREBBP PRRC2A TFAP4 TFCP2 | 1.87e-05 | 1443 | 54 | 14 | int:CEBPB |
| Interaction | CNOT3 interactions | 1.87e-05 | 207 | 54 | 6 | int:CNOT3 | |
| Interaction | RUVBL1 interactions | 1.99e-05 | 575 | 54 | 9 | int:RUVBL1 | |
| Interaction | CAPRIN1 interactions | 2.49e-05 | 451 | 54 | 8 | int:CAPRIN1 | |
| Interaction | MED15 interactions | 2.63e-05 | 131 | 54 | 5 | int:MED15 | |
| Interaction | ZBTB7A interactions | 2.63e-05 | 131 | 54 | 5 | int:ZBTB7A | |
| Interaction | CDK8 interactions | 2.77e-05 | 222 | 54 | 6 | int:CDK8 | |
| Interaction | ERG interactions | 2.85e-05 | 223 | 54 | 6 | int:ERG | |
| Interaction | NCOA3 interactions | 2.92e-05 | 224 | 54 | 6 | int:NCOA3 | |
| Interaction | PARP1 interactions | HDAC9 MAGI1 SP1 PHC3 BRD4 POU2F1 MLLT6 QRICH1 MGA CREBBP TFCP2 PHC1 TBP | 3.30e-05 | 1316 | 54 | 13 | int:PARP1 |
| Interaction | JUN interactions | 3.35e-05 | 470 | 54 | 8 | int:JUN | |
| Interaction | PHF21A interactions | 3.47e-05 | 343 | 54 | 7 | int:PHF21A | |
| Interaction | CNOT7 interactions | 3.62e-05 | 140 | 54 | 5 | int:CNOT7 | |
| Interaction | NUP43 interactions | 3.83e-05 | 625 | 54 | 9 | int:NUP43 | |
| Interaction | MED13L interactions | 3.92e-05 | 71 | 54 | 4 | int:MED13L | |
| Interaction | MED11 interactions | 3.92e-05 | 71 | 54 | 4 | int:MED11 | |
| Interaction | MAML1 interactions | 4.37e-05 | 73 | 54 | 4 | int:MAML1 | |
| Interaction | CPEB1 interactions | 4.43e-05 | 146 | 54 | 5 | int:CPEB1 | |
| Interaction | HNRNPD interactions | 4.49e-05 | 638 | 54 | 9 | int:HNRNPD | |
| Interaction | EYA4 interactions | 4.60e-05 | 243 | 54 | 6 | int:EYA4 | |
| Interaction | H3C3 interactions | 4.83e-05 | 495 | 54 | 8 | int:H3C3 | |
| Interaction | GPBP1 interactions | 4.86e-05 | 75 | 54 | 4 | int:GPBP1 | |
| Interaction | NCOR1 interactions | 4.96e-05 | 363 | 54 | 7 | int:NCOR1 | |
| Interaction | SP1 interactions | 5.14e-05 | 365 | 54 | 7 | int:SP1 | |
| Interaction | TFAP4 interactions | 5.53e-05 | 153 | 54 | 5 | int:TFAP4 | |
| Interaction | H2AC4 interactions | 5.63e-05 | 506 | 54 | 8 | int:H2AC4 | |
| Interaction | TBP interactions | 5.75e-05 | 253 | 54 | 6 | int:TBP | |
| Interaction | UBP1 interactions | 5.96e-05 | 79 | 54 | 4 | int:UBP1 | |
| Interaction | HMGB2 interactions | 6.41e-05 | 258 | 54 | 6 | int:HMGB2 | |
| Interaction | MED18 interactions | 6.57e-05 | 81 | 54 | 4 | int:MED18 | |
| Interaction | MED21 interactions | 6.64e-05 | 159 | 54 | 5 | int:MED21 | |
| Cytoband | 3p14.1 | 3.96e-04 | 24 | 56 | 2 | 3p14.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 3.34e-03 | 503 | 56 | 4 | chr6p21 | |
| Cytoband | 6p21.3 | 3.57e-03 | 250 | 56 | 3 | 6p21.3 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 5.39e-16 | 25 | 43 | 8 | 775 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 1.04e-06 | 9 | 43 | 3 | 755 | |
| GeneFamily | Cyclins|Mediator complex | 6.50e-05 | 33 | 43 | 3 | 1061 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 5.69e-04 | 15 | 43 | 2 | 26 | |
| GeneFamily | SRY-boxes | 9.21e-04 | 19 | 43 | 2 | 757 | |
| GeneFamily | PDZ domain containing | 5.62e-03 | 152 | 43 | 3 | 1220 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 6.69e-03 | 718 | 43 | 6 | 28 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 2.47e-07 | 206 | 55 | 7 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 2.63e-07 | 208 | 55 | 7 | MM581 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 5.59e-06 | 467 | 55 | 8 | M1347 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 7.26e-06 | 484 | 55 | 8 | MM999 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | 1.33e-05 | 526 | 55 | 8 | M2520 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | 2.80e-05 | 584 | 55 | 8 | MM1080 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 5.99e-05 | 198 | 55 | 5 | M9119 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 6.13e-05 | 199 | 55 | 5 | M7254 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 6.28e-05 | 200 | 55 | 5 | M9449 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 9.23e-05 | 217 | 55 | 5 | M16407 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 1.16e-04 | 228 | 55 | 5 | MM1014 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.18e-06 | 147 | 55 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 2.99e-05 | 139 | 55 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#1 | 3.64e-05 | 72 | 55 | 4 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | TRERF1 SOX6 MAGI1 PCLO TOX3 MED12L FMN2 POU2F1 MLLT6 SALL4 LIN7A | 3.64e-05 | 983 | 55 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 4.19e-05 | 247 | 55 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | 1.13e-04 | 428 | 55 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | 1.15e-04 | 429 | 55 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.18e-04 | 298 | 55 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.38e-04 | 192 | 55 | 5 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.24e-04 | 478 | 55 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.63e-04 | 654 | 55 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.67e-04 | 492 | 55 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | 2.67e-04 | 492 | 55 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 2.70e-04 | 493 | 55 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | 2.72e-04 | 836 | 55 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | 2.80e-04 | 496 | 55 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 2.87e-04 | 498 | 55 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | 3.07e-04 | 850 | 55 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#2 | 3.92e-04 | 55 | 55 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.19e-04 | 377 | 55 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 4.59e-04 | 249 | 55 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 6.43e-04 | 409 | 55 | 6 | gudmap_developingGonad_e12.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 7.12e-04 | 417 | 55 | 6 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 6.42e-08 | 166 | 56 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.49e-08 | 174 | 56 | 6 | 0fccd90ef72ec2e5eb369fe6d6d126c60886485a | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-06 | 173 | 56 | 5 | 5d7c53c6d1cdd385e44b79b82faec901747d1736 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-06 | 174 | 56 | 5 | b2fc2a756f8e373ad903bd416d9de703d945fa1c | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-06 | 174 | 56 | 5 | 9eab43885496b8586f8ec5b4bcb1fd5b209218e5 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.68e-06 | 186 | 56 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | control-immature_Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.75e-06 | 196 | 56 | 5 | e34fd3e7a5b1c22a81fd3208e6d58bdb846d51c4 | |
| ToppCell | Adult-Immune-dendritic_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.22e-05 | 154 | 56 | 4 | 64a4686586d08b1e9632dde917b472ac660de2d3 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.52e-05 | 165 | 56 | 4 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.52e-05 | 165 | 56 | 4 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.52e-05 | 165 | 56 | 4 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.25e-05 | 177 | 56 | 4 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.96e-05 | 187 | 56 | 4 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.53e-05 | 190 | 56 | 4 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-05 | 192 | 56 | 4 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 193 | 56 | 4 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 193 | 56 | 4 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 193 | 56 | 4 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.01e-04 | 193 | 56 | 4 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 193 | 56 | 4 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 194 | 56 | 4 | 5d0b0d8e96f0e0297a4dba70a05d87081a4eb323 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 194 | 56 | 4 | 6ac759828c41ffa974ee82842162caa959351dd1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 194 | 56 | 4 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 194 | 56 | 4 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.05e-04 | 195 | 56 | 4 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-04 | 197 | 56 | 4 | ff4df77117165b6b25315e29b0722cc136eba607 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.14e-04 | 199 | 56 | 4 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 56 | 4 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 56 | 4 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | 320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c | |
| Drug | Pt-F | 1.39e-06 | 81 | 54 | 5 | CID000013016 | |
| Drug | SP 0 | 1.50e-06 | 10 | 54 | 3 | CID002742752 | |
| Drug | AC1L2FXT | 1.50e-06 | 10 | 54 | 3 | CID000071316 | |
| Drug | A25618 | HDAC9 SP1 SP3 BRD4 POU2F1 FOXP1 CREBBP TFAP4 TFCP2 MED12 TBP | 1.71e-06 | 777 | 54 | 11 | CID000005562 |
| Drug | AC1L2XIZ | 2.73e-06 | 12 | 54 | 3 | CID000104803 | |
| Drug | Tadenan | 4.28e-06 | 46 | 54 | 4 | CID000012620 | |
| Drug | distamycin analog | 5.52e-06 | 2 | 54 | 2 | CID000371500 | |
| Drug | N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 7.11e-06 | 197 | 54 | 6 | 959_UP | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 7.32e-06 | 198 | 54 | 6 | 7035_UP | |
| Drug | Ungerine nitrate; Down 200; 10.2uM; MCF7; HT_HG-U133A | 7.53e-06 | 199 | 54 | 6 | 7173_DN | |
| Drug | AC1L2E0P | 7.79e-06 | 307 | 54 | 7 | CID000019390 | |
| Drug | NSC24559 | 1.04e-05 | 122 | 54 | 5 | CID000029051 | |
| Drug | homocysteic acid | 1.65e-05 | 3 | 54 | 2 | ctd:C007956 | |
| Drug | hyperoside | 2.46e-05 | 24 | 54 | 3 | ctd:C021304 | |
| Drug | ADP-ribosylarginine | 2.80e-05 | 25 | 54 | 3 | CID000126311 | |
| Drug | Sp 1 (pharmaceutical) | 4.20e-05 | 548 | 54 | 8 | CID000099040 | |
| Drug | AC1L8XYY | 5.50e-05 | 5 | 54 | 2 | CID000389459 | |
| Drug | poly(tetramethylene adipate | 5.50e-05 | 5 | 54 | 2 | CID000032794 | |
| Drug | 2,6-dihydroxybenzoic acid | 5.91e-05 | 175 | 54 | 5 | CID000009338 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.07e-05 | 176 | 54 | 5 | 1212_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 7.11e-05 | 182 | 54 | 5 | 3887_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 7.30e-05 | 183 | 54 | 5 | 7498_DN | |
| Drug | ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 9.16e-05 | 192 | 54 | 5 | 1076_UP | |
| Drug | Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 9.38e-05 | 193 | 54 | 5 | 6223_UP | |
| Drug | Tetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 9.38e-05 | 193 | 54 | 5 | 6209_UP | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 9.61e-05 | 194 | 54 | 5 | 4246_DN | |
| Drug | oxaprozin; Down 200; 300uM; MCF7; HT_HG-U133A_EA | 9.85e-05 | 195 | 54 | 5 | 863_DN | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.01e-04 | 196 | 54 | 5 | 4227_DN | |
| Drug | PF-00539745-00 [351321-33-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.01e-04 | 196 | 54 | 5 | 5974_DN | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; PC3; HT_HG-U133A | 1.01e-04 | 196 | 54 | 5 | 2073_UP | |
| Drug | Gabazine [105538-73-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.01e-04 | 196 | 54 | 5 | 3253_UP | |
| Drug | Pinacidil [85371-64-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 1.03e-04 | 197 | 54 | 5 | 5456_UP | |
| Drug | Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.03e-04 | 197 | 54 | 5 | 6233_UP | |
| Drug | Nicergoline; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.03e-04 | 197 | 54 | 5 | 5775_DN | |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.03e-04 | 197 | 54 | 5 | 2282_DN | |
| Drug | Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.03e-04 | 197 | 54 | 5 | 4717_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; PC3; HT_HG-U133A | 1.03e-04 | 197 | 54 | 5 | 1240_DN | |
| Drug | Sulfamethizole [144-82-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.03e-04 | 197 | 54 | 5 | 6099_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HG-U133A | 1.06e-04 | 198 | 54 | 5 | 201_DN | |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.08e-04 | 199 | 54 | 5 | 7311_DN | |
| Drug | Metolazone [17560-51-9]; Up 200; 11uM; PC3; HG-U133A | 1.08e-04 | 199 | 54 | 5 | 1932_UP | |
| Drug | AC1OC6D1 | 1.09e-04 | 104 | 54 | 4 | CID006368594 | |
| Drug | CTX-2 | 1.15e-04 | 7 | 54 | 2 | CID006441260 | |
| Drug | 3-(2-carboxyindol-3-yl)propionic acid | 1.46e-04 | 43 | 54 | 3 | CID000169313 | |
| Drug | CV-1 | 1.49e-04 | 213 | 54 | 5 | CID000130105 | |
| Drug | allylthiol | 1.53e-04 | 8 | 54 | 2 | CID000013367 | |
| Drug | AC1L9K70 | 2.04e-04 | 228 | 54 | 5 | CID000446871 | |
| Drug | thallium acetate | 2.45e-04 | 10 | 54 | 2 | CID000011247 | |
| Drug | di-n-butyl sebacate | 2.45e-04 | 10 | 54 | 2 | CID000007986 | |
| Disease | Huntington's disease (is_marker_for) | 3.18e-06 | 53 | 56 | 4 | DOID:12858 (is_marker_for) | |
| Disease | prostate carcinoma | 6.06e-06 | 891 | 56 | 10 | EFO_0001663 | |
| Disease | cortical surface area measurement | HDAC9 MAGI1 SP1 BMP6 SP4 TOX3 TNRC6B FOXP1 ZFHX3 PRRC2A TFAP4 | 3.81e-05 | 1345 | 56 | 11 | EFO_0010736 |
| Disease | Adenoid Cystic Carcinoma | 3.98e-05 | 100 | 56 | 4 | C0010606 | |
| Disease | cognitive function measurement, self reported educational attainment | 5.69e-05 | 355 | 56 | 6 | EFO_0004784, EFO_0008354 | |
| Disease | vital capacity | 9.85e-05 | 1236 | 56 | 10 | EFO_0004312 | |
| Disease | reticulocyte measurement | 1.52e-04 | 1053 | 56 | 9 | EFO_0010700 | |
| Disease | depressive symptom measurement | 1.54e-04 | 426 | 56 | 6 | EFO_0007006 | |
| Disease | Antithrombotic agent use measurement | 1.58e-04 | 55 | 56 | 3 | EFO_0009925 | |
| Disease | neuroimaging measurement | 1.70e-04 | 1069 | 56 | 9 | EFO_0004346 | |
| Disease | cortical thickness | 2.30e-04 | 1113 | 56 | 9 | EFO_0004840 | |
| Disease | red blood cell density measurement | 2.43e-04 | 880 | 56 | 8 | EFO_0007978 | |
| Disease | Schizophrenia | 2.48e-04 | 883 | 56 | 8 | C0036341 | |
| Disease | diastolic blood pressure, systolic blood pressure | 2.66e-04 | 670 | 56 | 7 | EFO_0006335, EFO_0006336 | |
| Disease | sclerosing cholangitis | 2.72e-04 | 66 | 56 | 3 | EFO_0004268 | |
| Disease | hepatoblastoma (is_marker_for) | 3.66e-04 | 15 | 56 | 2 | DOID:687 (is_marker_for) | |
| Disease | autism spectrum disorder, schizophrenia | 3.90e-04 | 327 | 56 | 5 | EFO_0003756, MONDO_0005090 | |
| Disease | unipolar depression | 4.14e-04 | 1206 | 56 | 9 | EFO_0003761 | |
| Disease | C-reactive protein measurement | 4.14e-04 | 1206 | 56 | 9 | EFO_0004458 | |
| Disease | schizophrenia (is_implicated_in) | 4.45e-04 | 78 | 56 | 3 | DOID:5419 (is_implicated_in) | |
| Disease | brain measurement, neuroimaging measurement | 6.01e-04 | 550 | 56 | 6 | EFO_0004346, EFO_0004464 | |
| Disease | hematocrit | 6.10e-04 | 1011 | 56 | 8 | EFO_0004348 | |
| Disease | Neurodevelopmental Disorders | 7.44e-04 | 93 | 56 | 3 | C1535926 | |
| Disease | obesity (implicated_via_orthology) | 7.48e-04 | 215 | 56 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | reticulocyte count | 7.57e-04 | 1045 | 56 | 8 | EFO_0007986 | |
| Disease | mean reticulocyte volume | 7.61e-04 | 799 | 56 | 7 | EFO_0010701 | |
| Disease | multisite chronic pain | 7.92e-04 | 95 | 56 | 3 | EFO_0010100 | |
| Disease | Parkinson disease | 7.98e-04 | 22 | 56 | 2 | cv:C0030567 | |
| Disease | peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease | 9.51e-04 | 24 | 56 | 2 | EFO_0003948, EFO_0009923, MONDO_0004247 | |
| Disease | congenital heart disease (is_implicated_in) | 9.51e-04 | 24 | 56 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | hair colour measurement | 1.07e-03 | 615 | 56 | 6 | EFO_0007822 | |
| Disease | Unipolar Depression | 1.49e-03 | 259 | 56 | 4 | C0041696 | |
| Disease | reaction time measurement | 1.51e-03 | 658 | 56 | 6 | EFO_0008393 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.58e-03 | 447 | 56 | 5 | EFO_0000694, MONDO_0100096 | |
| Disease | neuroticism measurement | 1.60e-03 | 909 | 56 | 7 | EFO_0007660 | |
| Disease | inflammatory bowel disease | 1.61e-03 | 449 | 56 | 5 | EFO_0003767 | |
| Disease | chronic obstructive pulmonary disease | 1.90e-03 | 688 | 56 | 6 | EFO_0000341 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QRHLLQQQEQQLQQL | 936 | P55198 | |
| QQQEQQLQQLQQLLA | 941 | P55198 | |
| EQLLLQKQLQQQQQQ | 276 | Q9Y2D5 | |
| RRQEQQQQQRQEQQQ | 1281 | O60885 | |
| NIQQALQQRILQQQQ | 2286 | Q92793 | |
| QQLEALQQQVKQLQN | 916 | Q9P0K7 | |
| EQQIQVQQPQQVQVQ | 91 | Q2TAL8 | |
| VQQPQQVQVQVQVQQ | 96 | Q2TAL8 | |
| SQQIRLQQQQAQQPL | 936 | Q9NVH2 | |
| PELEQQQEQQQEQQQ | 371 | P06727 | |
| ARRRQQQQLLIQQQQ | 206 | O14910 | |
| LQQQQQQRLLRQAQT | 1886 | Q86YW9 | |
| RKKQLEQQQQQQQQQ | 396 | Q96QZ7 | |
| QLQQLQQQGQATQVR | 1246 | Q6P4R8 | |
| EQRQQQQQQQQQILA | 761 | Q96JK9 | |
| QQQQQQQILAEQQLQ | 766 | Q96JK9 | |
| KQISLRQAQQQQQQQ | 966 | Q8IWI9 | |
| AQQRLQLEQIQQLQQ | 2446 | Q9UPA5 | |
| QLEQIQQLQQQLQQQ | 2451 | Q9UPA5 | |
| QQLQQQLQQQLEEQK | 2456 | Q9UPA5 | |
| LAQQQLQLEQIQQLQ | 3286 | Q9Y6V0 | |
| RQLLLQQQQQQQVSG | 66 | Q9H334 | |
| IQQQQQQLQRIAQLQ | 231 | Q96RN5 | |
| QQLQRIAQLQLQQQQ | 236 | Q96RN5 | |
| QQQQQTAALVRQLQQ | 2146 | Q93074 | |
| NNNEQLLVNQQAIQI | 16 | Q6ZN66 | |
| ILQQQQQQIQPITLQ | 326 | Q8NDX5 | |
| QIAQDLQQLQQLQQQ | 171 | P14859 | |
| QLQQQNLNLQQFVLV | 181 | P14859 | |
| NQQQVLQRNLEQEQQ | 396 | Q86YD1 | |
| IYKNRQRRQQQQQQQ | 66 | P0CG42 | |
| QQQEALRRLQQQQQQ | 901 | Q6Y7W6 | |
| LRRLQQQQQQQQLAQ | 906 | Q6Y7W6 | |
| ALRQQEEQQQQQQLP | 106 | P22004 | |
| QQAQQQLEEVRQNRQ | 506 | Q9H4E7 | |
| LQQELLLIQQQQQIQ | 46 | Q9UKV0 | |
| LTQRQRQRQQQQQQQ | 111 | A0A1B0GTI1 | |
| QAIRLQQQQQQQLQL | 201 | Q9NZ56 | |
| IRQERQQQQQQQQRS | 91 | Q6NYC8 | |
| QQLQQLIQTLQIQQQ | 201 | Q9UPN6 | |
| EQILCLQQQQLQQIQ | 216 | Q9UJQ4 | |
| LQQQQLQQIQLTEQI | 221 | Q9UJQ4 | |
| QQQQLQQQQQRDPEA | 371 | Q8N4C8 | |
| QIQIQQPQQQIIQAI | 406 | Q02446 | |
| QTIQTIQQQPLQNVQ | 431 | Q02446 | |
| QNYQGQIQEQIQVLQ | 136 | Q9BZY9 | |
| TITNLQQQIQQHQRQ | 1191 | Q9HCJ0 | |
| RFQRQQQEQLLKQQQ | 646 | P48634 | |
| QQQLLNQQVLEQRQQ | 251 | O00287 | |
| NQQTQQQQILIQPQL | 391 | P08047 | |
| RQQQEQIARQQQQLL | 231 | P35712 | |
| QIARQQQQLLQQQHK | 236 | P35712 | |
| IQQQHKINLLQQQIQ | 206 | Q9UN79 | |
| AEVQKQLQQRQQQQQ | 116 | P51449 | |
| QESLQLREQQQQQQQ | 396 | Q12800 | |
| KLNSVRQQQLQQQQQ | 66 | Q5TF21 | |
| ILEEQQRQQQQQQQQ | 51 | P20226 | |
| FQVQGVQNLQNLQIQ | 466 | Q02447 | |
| PRFQRQQQQQQQEQL | 626 | Q5JSZ5 | |
| QQQQQIHLQQKQVVI | 381 | P78364 | |
| QQQQQQQQAGQLRER | 1471 | Q68DE3 | |
| INQQQLQQQLQQRLQ | 501 | O15405 | |
| LQQQLQQRLQLQQLQ | 506 | O15405 | |
| ASSQQQQQQVQQLRQ | 171 | Q9UGU0 | |
| QQQQVQQLRQQLYQS | 176 | Q9UGU0 | |
| LQMEQQQQLQQRQIL | 106 | Q9NS69 | |
| QQQLQPQQVQEQQRL | 156 | P0CG23 | |
| PQQVQEQQRLQQQQE | 161 | P0CG23 | |
| EQQRLQQQQEQLQTQ | 166 | P0CG23 | |
| QLQTQQAQEQQVLQQ | 176 | P0CG23 | |
| QAQEQQVLQQQEQLQ | 181 | P0CG23 | |
| QVLQQQEQLQQQVQE | 186 | P0CG23 | |
| QEQLQQQVQEQQLLQ | 191 | P0CG23 | |
| QQVQEQQLLQQQQEQ | 196 | P0CG23 | |
| QQEQLQQQQQLLLLQ | 231 | P0CG23 | |
| QLQQQLLEQQQAQLQ | 261 | P0CG23 | |
| QAQLQQQLLLQQQEQ | 271 | P0CG23 | |
| QQLEQQLEQQQQQLE | 366 | P0CG23 | |
| QLEQQQQQLEQQEVQ | 371 | P0CG23 | |
| IAQQVQLQQQQEQVR | 191 | Q01664 | |
| LQQQQQQQLLQNQRK | 1286 | Q9UPQ9 | |
| LQEAIQQQQQRQLQQ | 3371 | Q15911 | |
| QQQPQQLQLQQRQGS | 306 | Q96PN7 |